Study Summary
This is a single-center, double-arm, open-label study. this study plans to evaluate the safety and efficacy of CD70-targeting CAR-T cells in the treatment of CD70-positive advanced/metastatic solid tumors, and obtain recommended doses and infusion patterns.
Want to learn more about this trial?
Request More InfoInterventions
CD70 CAR-T cellsBIOLOGICAL
After lymphodepletion with Fludarabine and Cyclophosphamide,CAR T cells were transfused intravenically
CD70 CAR-T cellsBIOLOGICAL
After lymphodepletion with Fludarabine and Cyclophosphamide,CAR T cells were injected intraperitoneally
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The First Affiliated Hospital of Nanchang University | Nanchang | Jiangxi | China |